[{"Assets_0_Q3_USD":205706000.0,"CommonStockSharesOutstanding_0_Q3_shares":44922724.0,"NetIncomeLoss_3_Q3_USD":-13729000.0,"NetIncomeLoss_1_Q3_USD":-4550000.0,"StockholdersEquity_0_Q3_USD":130469000.0,"Ticker":"VNDA","CIK":"1347178","name":"VANDA PHARMACEUTICALS INC.","OfficialName":"Vanda Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"633424667.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171108"}]